These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2682251)

  • 1. Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies.
    Polonelli L; Conti S; Magliani W; Morace G
    Mycopathologia; 1989 Jul; 107(1):17-23. PubMed ID: 2682251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological typing methods for mycoses.
    Pfaller MA
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S4-10. PubMed ID: 1562694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of opportunistic filamentous fungi present in the CBS culture collection.
    de Hoog GS; Tan CS; Stalpers JA; Stegehuis G
    Mycoses; 1992; 35(9-10):209-14. PubMed ID: 1291870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotyping of bacterial isolates using the yeast killer system.
    Morace G; Manzara S; Dettori G; Fanti F; Conti S; Campani L; Polonelli L; Chezzi C
    Eur J Epidemiol; 1989 Sep; 5(3):303-10. PubMed ID: 2676582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunistic zygomycotic infections. A literature review.
    Espinel-Ingroff A; Oakley LA; Kerkering TM
    Mycopathologia; 1987 Jan; 97(1):33-41. PubMed ID: 3550467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidden killers: persistence of opportunistic fungal pathogens in the human host.
    d'Enfert C
    Curr Opin Microbiol; 2009 Aug; 12(4):358-64. PubMed ID: 19541532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunistic and pathogenic fungi.
    Richardson MD
    J Antimicrob Chemother; 1991 Jul; 28 Suppl A():1-11. PubMed ID: 1938702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of killer sensitivity patterns for biotyping yeast strains: the state of the art, potentialities and limitations.
    Buzzini P; Turchetti B; Vaughan-Martini AE
    FEMS Yeast Res; 2007 Sep; 7(6):749-60. PubMed ID: 17425671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.
    Pfaller MA; Diekema DJ
    J Clin Microbiol; 2004 Oct; 42(10):4419-31. PubMed ID: 15472288
    [No Abstract]   [Full Text] [Related]  

  • 10. Emerging fungal pathogens.
    Anaissie EJ; Bodey GP; Rinaldi MG
    Eur J Clin Microbiol Infect Dis; 1989 Apr; 8(4):323-30. PubMed ID: 2497012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic yeasts.
    Stenderup A
    Yeast; 1989 Apr; 5 Spec No():S215-24. PubMed ID: 2665355
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-culture-based diagnostics for opportunistic fungi.
    Mennink-Kersten MA; Verweij PE
    Infect Dis Clin North Am; 2006 Sep; 20(3):711-27, viii. PubMed ID: 16984877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cabanillasin, a new antifungal metabolite, produced by entomopathogenic Xenorhabdus cabanillasii JM26.
    Houard J; Aumelas A; Noël T; Pages S; Givaudan A; Fitton-Ouhabi V; Villain-Guillot P; Gualtieri M
    J Antibiot (Tokyo); 2013 Oct; 66(10):617-20. PubMed ID: 23756685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New aspects of emerging fungal pathogens. A multifaceted challenge.
    Schell WA
    Clin Lab Med; 1995 Jun; 15(2):365-87. PubMed ID: 7671578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killer systems and pathogenic fungi.
    Polonelli L; Morace G
    Eur J Epidemiol; 1988 Dec; 4(4):415-8. PubMed ID: 3203721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The most common pathogens in opportunistic mycoses and their clinical manifestations].
    Háber J; Kolesková E; Straub J; Klener P
    Vnitr Lek; 1993 Dec; 39(12):1192-8. PubMed ID: 8310670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of invasive mycoses in North America.
    Pfaller MA; Diekema DJ
    Crit Rev Microbiol; 2010; 36(1):1-53. PubMed ID: 20088682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Yeasts and Filamentous Fungi using MALDI Lipid Phenotyping.
    Stübiger G; Wuczkowski M; Mancera L; Lopandic K; Sterflinger K; Belgacem O
    J Microbiol Methods; 2016 Nov; 130():27-37. PubMed ID: 27546717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-microbe interactions: fungi invasive human fungal opportunistic infections.
    Latgé JP; Calderone R
    Curr Opin Microbiol; 2002 Aug; 5(4):355-8. PubMed ID: 12160852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.